Ponda Raises $1.8M in Crow

eEnergy

eEnergy helps organisations reduce energy costs, improve efficiency and reinvest savings into what matters most. As a UK Energy-as-a-Service provider, we fund and deliver energy-saving and energy-generating solutions for public sector and commercial organisations with multi-site estates - with zero upfront cost. Our solutions include: Reduce: LED lighting and intelligent controls Generate: Solar PV for rooftops, ground mounts and car parks Store: Battery storage to maximise onsite generation and reduce peak-time energy costs Charge: EV charging infrastructure and management Through our dedicated funding facilities, including up to £100m of project funding through our partnership with Redaptive, organisations can access the upgrades they need without the upfront capital investment. We work across Education, Healthcare, Public Sector and Commercial & Industrial (C&I), helping organisations tackle rising energy costs while improving the performance and resilience of their estates. Our routes to market include direct sales, public sector frameworks, tenders and strategic partnerships. We hold positions on major procurement frameworks including CCS, LASER, Lexica/NHS London, NHS Commercial Solutions and YPO, and are an Office for Zero Emission Vehicles (OZEV) approved EV charge point installer. With more than 1,200 projects delivered, around 590,000 LEDs installed and improvements made to learning environments used by approximately 520,000 students, we have a proven track record of delivering practical energy improvements at scale. eEnergy is a market leader in the education sector, has been awarded the London Stock Exchange Green Economy Mark, and was recognised in the 2025 UK Fast Growth 50 Index's Fastest Growing Green Firms. We also hold an EcoVadis Bronze Medal, with a score of 61/100, placing us in the top third of more than 130,000 organisations assessed globally. Save energy. Save money. Reinvest in what matters.

Simpl

... UNDER CONSTRUCTION

Magnitude Biosciences Ltd

An innovative C. elegans company, using our expertise and technology to provide quantified non-invasive assays of health outcomes for biotech, nutrition and other industries and research interests. - Prescreen compounds to reduce the number of experiments in mammals - Find effective and safe concentration ranges - Test mutants in signalling pathways - Screen libraries of mutants - Screen compound libraries - Combine compounds and mutants - Adapt technology to address your questions We are a team of experts with a proven track record of: Designing customised C. elegans studies to provide answers to your specific ageing research questions Integrating C. elegans into drug discovery pipelines Working with innovative biotech and pharma companies Providing relevant, standardised, data rich assays